Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Wockhardt

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Wockhardt's 2013 sales performance.

India denies Vertex patent on cystic fibrosis drug Orkambi

India denies Vertex patent on cystic fibrosis drug Orkambi

The patent was opposed by the Indian Pharmaceutical Alliance (IPA), a trade organisation representing India's larger pharmaceutical companies, including Cipla, Dr Reddy's Labs, Lupin, Nicholas Piramal, Ranbaxy and Wockhardt.

Opportunities in the medical devices sector in India

Opportunities in the medical devices sector in India Leading private hospitals that are currently controlling the country's healthcare sector include Apollo Hospitals Enterprise, Fortis Healthcare, Wockhardt Hospitals, Max Hospitals, Aravind Eye Hospitals and Manipal Hospitals, among others. .

Lilly wins Cymbalta exclusivity

Lilly filed the suit in 2008 after Wockhardt submitted an abbreviated new drug application with the US Food and Drug Administration (FDA) seeking approval of its generic Cymbalta product. ... Wockhardt last month and has now issued a new order requiring

Takeda settles Actos patent suits

The lawsuits were filed in response to abbreviated new drug applications (ANDA) submitted to the FDA by Mylan, Watson, Ranbaxy, Sandoz, Teva, Alphapharm, Torrent, Dr Reddy's Laboratories, Wockhardt, Synthon, and ... FDA. Takeda's settlements with

Slim pickings

Metoprolol . (Wockhardt). Hypertension, angina. US. N-acetyl-s-farnsylcysteine. Arazine (Rohto Pharmaceutical). Inflammation . Japan.

1 2 3 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics